Pair of surveys provide a rare formal peek into the relationship between sponsors and pediatric clinical research networks. A lack of awareness, incongruent expectations, and insufficient communication have hindered collaboration between the two parties. Developing standardized procedures and better information exchange could help strengthen the connection going forward.
While several studies and surveys have examined the relationship between sponsors and CROs, there has been little analysis of CRO-investigative site relationships. This study uncovers useful learnings on the positive and negative experiences of investigators in their direct dealings with CROs.
This overview of clinical supply blinding methods addresses questions about this topic in the context of the current research environment. The recommendations for protecting the blind come at an important time for the industry and may help fill a gap left by the lack of training resources and published material about this subject.
Clinical Trial Budgeting and Forecasting
February 08, 2016 - February 09, 2016 Philadelphia, PA
Expanded Access Programs 2016
February 23, 2016 - February 24, 2016 Washington DC
SCOPE Summit for Clinical Ops Executives
February 23, 2016 - February 25, 2016 Miami, FL
Patient Centric Clinical Innovation Conference
March 03, 2016 - March 04, 2016 Philadelphia, PA
March 14, 2016 - March 25, 2016 Barcelona, Spain
CBI’s Clinical Technology Congress
March 29, 2016 - March 30, 2016 Philadelphia, PA
A substantial increase in procedure complexity should be reflected in increasing per patient costs of Phase III clinical trials,which is not true from this data.
The number of countries used in commercially sponsored Phase III clinical trials has not changed in recent years.
IMS data show the importance of the role clinical investigators play in prescribing.
Catalent Clinical Supply Services enlisted Applied Clinical Trials to develop an eBook that includes the best articles on conducting clinical trials in the Asia-Pacific region. Those articles include: the growing data management services market in China; navigating clinical supply challenges in Asia-Pac regional studies; trends in clinical trials placement, including South Korea as a destination for early phase trials and a look at the future of biosimilars development and steps to develop a logical sourcing strategy. SPONSORED
OmniComm Systems enlisted Applied Clinical Trials to conduct a survey on eSource and discovered our audience needed more tools to understand this growing technology area. Based on the results, they crafted a targeted webinar, a successful white paper and sponsored this eBook that features educational articles around eSource and links to OmniComm resources. SPONSORED
As the use of PRO expands in clinical trials, ePRO vendors have expanded beyond this constrained definition. Increasingly, the use of eCOA is being used to encompass all data collected related to the patient, which includes PRO, clinician reported (ClinRO) and observer or caregiver reported outcomes (ObsRO). This e-Book tackles the changing world of PRO collection in clinical trials.